학술논문
Pralsetinib and Sequential MET Inhibitors to Overcome MET Amplification Resistance in a Patient With a RET Fusion Driven Lung Cancer – Case Report
Document Type
Author
Source
In Clinical Lung Cancer December 2022 23(8):e568-e572
Subject
Language
ISSN
1525-7304